Exhaled nitric oxide levels in non-allergic and allergic mono- or polysensitised children with asthma

M Silvestri, F Sabatini, D Spallarossa, L Fregonese, E Battistini, M G Biraghi, G A Rossi, M Silvestri, F Sabatini, D Spallarossa, L Fregonese, E Battistini, M G Biraghi, G A Rossi

Abstract

Background: Increased fractional exhaled NO concentrations (FENO) and blood/tissue eosinophilia are frequently reported in allergic children with mild asthma and are thought to reflect the intensity of the inflammation characterising the disease. The aim of this study was to investigate possible differences in FENO levels or in the intensity of the blood eosinophilia in allergic and non-allergic asthmatic children.

Methods: 112 children with stable, mild, intermittent asthma with a positive bronchial challenge to methacholine were consecutively enrolled in the study; 56 were skin prick test and RAST negative (non-sensitised) while 56 were sensitised to house dust mites (23 only to house dust mites (monosensitised) and 33 were sensitised to mites and at least another class of allergens (pollens, pet danders, or moulds)). Nineteen sex and age matched healthy children formed a control group.

Results: Compared with non-allergic patients, allergic children had a significantly higher rate of blood eosinophilia (p=0.0001) with no differences between mono- and polysensitised individuals. Forced expiratory volume in 1 second (FEV(1)), forced vital capacity (FVC), forced expiratory flow at 25-75% of vital capacity (FEF(25-75%)), and the degree of bronchial reactivity to methacholine were similar in non-atopic and atopic children, with no differences between mono- and polysensitised individuals. FENO levels measured by chemiluminescence analyser were higher in asthmatic children (15.9 (14.3) ppb) than in the control group (7.6 (1.6) ppb, p=0.04) and higher in allergic patients (23.9 (2.1) ppb) than in non-allergic patients (7.9 (0.8) ppb, p=0.0001), but there were no differences between mono- and polysensitised individuals (p>0.1). Significant correlations between blood eosinophilia and FENO levels were seen only in allergic (r=0.35, p<0.01) and in polysensitised individuals (r=0.45, p<0.05).

Conclusions: In children with mild asthma, a similar degree of functional disease severity may be associated with a higher inflammatory component in allergic than in non-allergic subjects.

References

    1. Cell. 1994 Sep 23;78(6):915-8
    1. Eur Respir J. 1999 Jun;13(6):1386-90
    1. J Allergy Clin Immunol. 1996 Mar;97(3):768-72
    1. Am J Respir Crit Care Med. 1996 Aug;154(2 Pt 1):308-17
    1. Allergy. 1996 Feb;51(2):100-7
    1. BMJ. 1996 Sep 21;313(7059):744
    1. Eur J Pediatr. 1996 Aug;155(8):698-701
    1. Eur Respir J. 1999 Oct;14(4):897-901
    1. Am J Respir Crit Care Med. 2000 Mar;161(3 Pt 1):685-7
    1. Am J Respir Crit Care Med. 2000 Mar;161(3 Pt 1):694-9
    1. Thorax. 2000 Jun;55(6):484-8
    1. Eur Respir J. 2000 May;15(5):839-43
    1. J Allergy Clin Immunol. 2000 Oct;106(4):638-44
    1. J Allergy Clin Immunol. 1990 Feb;85(2):422-36
    1. J Allergy Clin Immunol. 1991 May;87(5):893-910
    1. Am Rev Respir Dis. 1992 Apr;145(4 Pt 1):890-9
    1. Am Rev Respir Dis. 1992 Jun;145(6):1469-76
    1. Am Rev Respir Dis. 1992 Jul;146(1):109-15
    1. Am J Respir Cell Mol Biol. 1993 Jan;8(1):35-42
    1. Am Rev Respir Dis. 1992 Aug;146(2):500-6
    1. Am Rev Respir Dis. 1993 Aug;148(2):523-32
    1. Am J Respir Cell Mol Biol. 1993 Oct;9(4):371-7
    1. Am J Respir Crit Care Med. 1996 Nov;154(5):1497-504
    1. J Allergy Clin Immunol. 1996 Nov;98(5 Pt 2):S27-33; discussion S33-40
    1. Eur Respir J. 1996 Nov;9(11):2231-5
    1. J Pediatr. 1997 Mar;130(3):423-7
    1. Eur Respir J. 1997 Mar;10(3):624-32
    1. J Immunol. 1997 Apr 1;158(7):3539-44
    1. Lung. 1997;175(4):277-85
    1. Eur Respir J. 1997 Jul;10(7):1483-8
    1. Eur Respir J. 1997 Sep;10(9):2097-104
    1. J Pediatr. 1997 Sep;131(3):381-5
    1. Ann Allergy Asthma Immunol. 1997 Dec;79(6):512-6
    1. Am J Respir Crit Care Med. 1998 Jan;157(1):4-9
    1. J Asthma. 1998;35(6):489-96
    1. Am J Respir Crit Care Med. 1998 Oct;158(4):1032-6
    1. Eur Respir J. 1999 Feb;13(2):321-6
    1. Immunol Today. 1995 Mar;16(3):128-30

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe